Literature DB >> 2981962

Genome differences among field isolates and vaccine strains of pseudorabies virus.

A L Gielkens, J T Van Oirschot, A J Berns.   

Abstract

The DNA of field isolates and vaccine strains of pseudorabies virus (PRV) was analysed by digestion with the restriction endonuclease BamHI. A number of distinct restriction profiles of the field isolates obtained from different locations within Europe were observed. As for herpes simplex virus, the variations could be classified into two types: first, alterations in the mobility of fragments due to the presence of additional sequences and/or the occurrence of deletions, a phenomenon most apparent in fragments containing part or whole of the repeat sequence of PRV DNA; second, generation of differently sized fragments due to loss and/or gain of restriction endonuclease cleavage sites. By analysis of several strains with BamHI a small number of variable cleavage sites were identified within particular regions of the unique long (UL) segment of the PRV genome. Compared to wild-type PRV, the restriction fragment patterns of vaccine strains showed characteristic alterations, including the absence of bands, which were non-variable in wild-type strains, and/or the presence of new bands some of which were submolar. Some of these characteristics could be explained by a deletion in the unique short (US) region of the genome of most vaccine strains and the occurrence of closely related variants in the uncloned vaccine virus stocks.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981962     DOI: 10.1099/0022-1317-66-1-69

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Role of a structural glycoprotein of pseudorabies in virus virulence.

Authors:  T C Mettenleiter; L Zsak; A S Kaplan; T Ben-Porat; B Lomniczi
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Restriction fragment pattern (RFP) analysis of genomes from Danish isolates of suid herpesvirus 1 (Aujezsky's disease virus).

Authors:  L S Christensen; K J Soerensen; J C Lei
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Restriction fragment pattern analysis of genomes from French isolates of suis herpes virus 1 (Aujeszky's disease virus).

Authors:  A Jestin; P Blanchard; A Garbar-Chenon; P Vannier; J C Nicolas
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Comparison by restriction fragment pattern analysis and molecular characterization of some European isolates of Suid herpesvirus 1: a contribution to strain differentiation of European isolates.

Authors:  L S Christensen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Linker insertion mutagenesis of herpesviruses: inactivation of single genes within the Us region of pseudorabies virus.

Authors:  N de Wind; A Zijderveld; K Glazenburg; A Gielkens; A Berns
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Role of pseudorabies virus glycoprotein gI in virus release from infected cells.

Authors:  T C Mettenleiter; C Schreurs; F Zuckermann; T Ben-Porat
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

7.  Host cell-specific growth advantage of pseudorabies virus with a deletion in the genome sequences encoding a structural glycoprotein.

Authors:  T C Mettenleiter; B Lomniczi; N Sugg; C Schreurs; T Ben-Porat
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Regeneration of herpesviruses from molecularly cloned subgenomic fragments.

Authors:  M van Zijl; W Quint; J Briaire; T de Rover; A Gielkens; A Berns
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Replication and virulence of pseudorabies virus mutants lacking glycoprotein gX.

Authors:  D R Thomsen; C C Marchioli; R J Yancey; L E Post
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

10.  High frequency intergenomic recombination of suid herpesvirus 1 (SHV-1, Aujeszky's disease virus).

Authors:  L S Christensen; B Lomniczi
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.